WhatsApp Skip to main content

Dr. Harsh J Shah

Pancreatic Cancer That Has Spread: What Can Be Done?

Last updated: 09-Nov-2026

Dr Harsh Shah, pancreas cancer surgeon, Ahmedabad

Dr Harsh Shah
MS, MCh (Surgical Gastroenterology), DrNB (Surgical Gastroenterology)
Registered with Gujarat Medical Council, Reg. No. G-38738
Pancreas Cancer Surgeon
Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad · 18 years of experience

In short

Metastatic means the cancer has reached other organs, most often the liver or the lining of the belly. An operation cannot remove it for good, so the main treatment is chemotherapy that works through the whole body.

The drugs are chosen by your strength, your blood tests and the gene tests on the biopsy. A few patients have a change in a gene that opens an extra option.

Treatment aims to hold the cancer back, ease symptoms and protect your strength and time with family. Pain relief, bile duct stents and good nutrition start from the first visit, alongside the drugs.

This post explains the options step by step. For the wider picture, see our pancreatic cancer treatment page.

What does metastatic pancreatic cancer mean?

It means cancer cells have left the pancreas and settled in another organ, so the disease is no longer in one place. The scan shows spots in the liver, the belly lining or, less often, the lungs.

Pancreatic cancer spreads early, often before it causes symptoms. By the time of diagnosis, many patients already have spots that are too small or too many to remove. The word does not mean treatment is useless. It means the aim changes from removal to control, and the plan must treat the whole body.

Where metastatic cancer sits among pancreatic cancer stages
Stage on scanMain featureWhat usually comes first
Resectable or borderlineConfined to the pancreas area, with little or some vessel contactOperation, or chemotherapy and then operation
Locally advancedWraps an artery, no distant spreadChemotherapy for months, then a fresh decision
MetastaticCancer seen in the liver, belly lining or lungsChemotherapy for control and comfort

Our post on how pancreatic cancer is staged shows how the scans are read. If the tumour is still near the pancreas only, see our post on locally advanced pancreatic cancer.

Is chemotherapy still worth it?

Yes, for patients who are strong enough. Chemotherapy slows the cancer, eases symptoms and, in trials, gave patients more time than no drugs or an older single drug.

The first step is a needle biopsy to prove the diagnosis, and a stent if the eyes are yellow. Then the team looks at four things before any drug is chosen.

  • How well you walk, eat and carry out daily tasks.
  • Blood counts, liver and kidney tests, and the state of the heart.
  • Your age and other illnesses, such as diabetes.
  • Gene tests on the biopsy, which can change the choice of drugs.

If you are weak from weight loss or jaundice, the first weeks go to building strength. Many patients become fit enough for drugs after a stent and a few weeks of good nutrition. Chemotherapy is not forced on anyone. If you are too unwell, comfort care is the right plan, and the section at the end of this post covers it.

Which drug combination is chosen?

A fit patient is usually offered a multi-drug combination, such as FOLFIRINOX or NALIRIFOX. Gemcitabine with nab-paclitaxel suits older patients or those who are less fit.

Common first drug choices for metastatic pancreatic cancer
ChoiceWho it suitsPoints to know
FOLFIRINOXFit patients with good blood, liver and kidney testsStrong effect, but tiring. Diarrhoea, low counts and numb fingers are watched for
NALIRIFOXFit patients, as another choice of similar strengthA newer four-drug combination that uses a long-acting form of irinotecan. In a large trial it gave more time than gemcitabine with nab-paclitaxel. Diarrhoea is common
Gemcitabine with nab-paclitaxelOlder or less fit patientsGentler on the body, and often easier to continue for longer. Numb fingers and low counts occur
Gemcitabine alone, or a lower-dose planFrail patients or those with other serious illnessMild, but a smaller effect. Chosen when strength is the limit

A cycle is usually given every two weeks, or three weeks out of four, depending on the drugs. A scan and the CA 19-9 blood test are repeated after about two to three months. If the cancer is controlled and you cope well, treatment continues. If side effects are heavy, doses are lowered rather than stopping the treatment. Your medical oncologist gives the drugs, and Dr Harsh Shah works with that team on the surgical and procedural side.

Can gene tests open other options?

Sometimes. A small number of patients have a change in a gene that makes a specific drug useful. This is why gene tests on the biopsy, and sometimes a blood test, are done early.

  • BRCA or PALB2 change. These tumours respond well to platinum drugs such as oxaliplatin. If the cancer is controlled after a few months, a tablet called olaparib may be used to keep it quiet.
  • MSI-high or mismatch repair loss. This is uncommon, but immunotherapy with pembrolizumab can work very well in these patients.
  • Rare fusions, such as NTRK, RET or a BRAF change. Targeted tablets exist for these changes, whatever the organ.
  • KRAS G12C. A small group can use a targeted tablet, mostly after the first drugs.

Most patients do not have one of these changes, and that is normal. A test with no target does not mean you are being treated less well. Because some of these drugs are costly, the oncologist also checks what can be obtained in India. Our post on what the pancreas biopsy report and gene tests mean explains the report.

What if the first drugs stop working?

A second line is offered to patients who are still fit enough. The choice depends on what was used first, so the second line is a switch to a different group of drugs.

  • After FOLFIRINOX, gemcitabine with nab-paclitaxel is the usual next step.
  • After gemcitabine with nab-paclitaxel, a fluorouracil-based plan with irinotecan, such as FOLFIRINOX or liposomal irinotecan, is used.
  • A patient with a BRCA change who has had platinum may move to olaparib.
  • A newer tablet aimed at the RAS gene, which is changed in most pancreatic cancers, has shown a clear gain in a large trial of patients treated before. It is not yet available in India, so it should not be promised.

Between lines of treatment, a short break is sometimes planned to recover from nerve and bowel side effects. Some patients on FOLFIRINOX move to a gentler maintenance plan once the cancer is steady, which protects the fingers and toes. Each change is explained to you, and you decide with the team.

How are pain, jaundice and weight loss handled?

Symptoms are treated at the same time as the cancer, not after it. Good symptom care often helps patients feel stronger and cope better with chemotherapy.

Common symptoms in metastatic pancreatic cancer and what helps
ProblemWhat helps
Deep back or belly painRegular pain medicines adjusted early. A nerve block near the coeliac artery, done by endoscopic ultrasound or through the skin, can ease the pain
Yellow eyes and itchingA stent placed through an endoscope opens the bile duct. A metal stent stays open longer than a plastic one
Vomiting after mealsA stent or a bypass lets food leave the stomach
Loose, oily stools and weight lossEnzyme capsules with meals, protein-rich food and a dietitian
High blood sugarTablets or insulin, with regular checks
Fluid in the bellyA small tube drains the fluid in a day-care visit
Low mood and worryCounselling, family support and, when needed, medicines

Blood clots in the legs or lungs are more common in pancreatic cancer. Swelling of one leg, sudden breathlessness or chest pain needs urgent attention. Walking daily, drinking enough water and eating small, frequent meals all help.

Is there any role for surgery?

For most patients with metastatic disease, no. Operating first does not remove the spread, and it costs strength that chemotherapy needs. Surgery is considered only in very selected patients, after drugs have worked.

  • A single spot in the liver or lung that stays alone after months of response may be treated by an operation or focused radiation.
  • A spot that appears long after a first operation is judged differently from spread present at diagnosis.
  • The scan should show a clear response, and the CA 19-9 level should have fallen.
  • The decision is made at a team meeting of surgeon, oncologist and radiologist, and it is rare.

Procedures that relieve problems are different from surgery to remove cancer. A stent, a bypass for a blocked stomach outlet or a nerve block are done when needed, because they help you live more comfortably. They are not a sign that the treatment has failed. Be wary of any offer of a major operation as the first step for spread cancer. Ask for a second opinion at a high-volume pancreas centre.

When does comfort care become the main plan?

When strength is too low for drugs to help, or when the cancer has stopped responding to every option, the plan moves to comfort. Comfort care aims at relief, dignity and time at home.

Palliative care is not a last step. A palliative care team can join from the first weeks, and it works alongside chemotherapy. It treats pain, breathlessness, poor appetite, sleep problems and worry, and it helps the family plan ahead.

  • Pain is controlled with the right medicines, in the right dose, at the right times.
  • Nutrition is kept simple and comfortable, with foods you enjoy.
  • Care can often be given at home, with visits when needed.
  • Talks about wishes and the family’s needs are held openly and kindly, at your pace.

Choosing comfort care is not giving up. It is a decision to use your remaining strength for the things that matter most to you. Dr Harsh Shah will tell you honestly what to expect, and will stay with you through each stage.

Frequently asked questions

What does metastatic pancreatic cancer mean?

It means the cancer has spread from the pancreas to another organ, most often the liver or the lining of the belly. It can no longer be removed by an operation alone, so treatment works through the whole body.

Can metastatic pancreatic cancer be operated on?

Usually not. Surgery does not remove spread cancer, and it can cost the strength chemotherapy needs. A very small group with a single, well-controlled spot after a clear response to drugs may be considered at a team meeting.

Which chemotherapy is used for metastatic pancreatic cancer?

A fit patient is usually offered FOLFIRINOX or NALIRIFOX. Older or weaker patients are offered gemcitabine with nab-paclitaxel. The choice depends on strength, blood tests and gene results.

Why are gene tests done on the biopsy?

A small group of patients has a change, such as BRCA, PALB2, MSI-high or a rare fusion, that makes a specific drug useful. Testing early avoids missing this chance.

What happens if the first chemotherapy stops working?

If you are still fit, a second-line plan is offered. It is usually a switch to a different group of drugs. If strength is low, comfort care becomes the main plan.

How is pain controlled in metastatic pancreatic cancer?

Pain medicines are adjusted early. A nerve block near the coeliac artery, done through the skin or by endoscopic ultrasound, can ease deep back pain. Radiation may also help in selected patients.

What if the bile duct or the stomach outlet gets blocked?

A stent placed through an endoscope opens the bile duct. A blocked stomach outlet is opened with a stent or a bypass operation. These steps let you eat and feel better while treatment continues.

Is palliative care the same as giving up?

No. Palliative care can start with chemotherapy, and it treats pain, appetite, sleep and worry. It helps patients and families feel supported at every stage.

Related pages

For the whole treatment pathway, start at the pancreatic cancer treatment page. For questions before you travel, call +91-63555-64601.

Where Dr Harsh Shah sees patients and operates

Dr Harsh Shah — Dr. Jivraj Mehta Hospital, Vasna, Ahmedabad
Dr. Jivraj Mehta Hospital, Dr Jivraj Mehta Marg, Vasna, Ahmedabad 380007.
Consultations, review of reports and scans, operations and follow-up. OPD Monday to Saturday, 9 am to 5 pm.
Appointments: +91-63555-64601 · +91-63590-11009 · Hospital 079-2663 6363
Directions to the hospital · WhatsApp +91-63555-64601

Has a scan told you that pancreatic cancer is now in the liver or the lining of the belly? The shock is real, and so are the choices that follow. Dr Harsh Shah reads your reports himself, explains which treatments fit your strength, and plans each step with your oncologist. Bring your scans, biopsy report and any chemotherapy papers. You can also call, or message us on WhatsApp. Call For Appointment Book on WhatsApp Tapping Book on WhatsApp will likely open the WhatsApp app on your phone.

Get health updates from Dr Harsh Shah on WhatsApp

Swasth Parivar: every week, practical advice on recovery, diet and warning signs. No advertising. Stop any time.

Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.

Dr. Harsh J Shah
Dr Harsh Shah, Gastro, Cancer & Laparoscopic Surgeon, Ahmedabad
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.